Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,693,787
+$3,246,190 QoQ
Shares Held
64,106
+768.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#634
of 2,506 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 11%
Shared 0%
None 89%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Voleon Capital Management LP holds $188,095,544 across 10 Drug Manufacturers - General names. BMY ranks #7 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
53,311 | $63,942,818 | |
| 2 | ABBV |
AbbVie Inc.
|
172,753 | $43,471,564 | |
| 3 | MRK |
Merck & Co., Inc.
|
295,499 | $37,971,621 | |
| 4 | AZN |
Astrazeneca PLC
|
125,385 | $23,775,503 | |
| 5 | JNJ |
Johnson & Johnson
|
28,917 | $7,344,050 | |
| 6 | SNY |
Sanofi
|
89,489 | $3,817,600 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
64,106 | $3,693,787 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
23,049 | $2,912,010 |
All Filings in BMY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,693,787 | 64,106 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $447,597 | 7,380 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $358,485 | 6,646 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,160,783 | 25,738 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $725,549 | 15,674 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $2,110,423 | 37,313 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||